Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/14/2000 | EP1007669A1 A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses |
06/14/2000 | EP1007668A1 Human pancreatitis-associated protein, pap-2 |
06/14/2000 | EP1007667A1 Nucleic acids encoding sperm antigens and reprosa-i polypeptides |
06/14/2000 | EP1007666A1 Neurturin receptor |
06/14/2000 | EP1007665A1 Two human homologues of galectin-5 |
06/14/2000 | EP1007664A1 Therapies involving mutated heat shock transcription factor |
06/14/2000 | EP1007663A2 Human proteins |
06/14/2000 | EP1007662A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio |
06/14/2000 | EP1007661A2 Secreted proteins and polynucleotides encoding them |
06/14/2000 | EP1007660A2 Secreted proteins and polynucleotides encoding them |
06/14/2000 | EP1007659A2 Tumor necrosis factor receptors 6 alpha & 6 beta |
06/14/2000 | EP1007654A1 In vitro peptide or protein expression library |
06/14/2000 | EP1007653A1 Polypeptides comprising a coiled-coil and an addition site |
06/14/2000 | EP1007652A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
06/14/2000 | EP1007650A1 Pca3, pca3 genes, and methods of use |
06/14/2000 | EP1007648A1 Anti-obesity proteins |
06/14/2000 | EP1007647A1 High level of expression of ingap |
06/14/2000 | EP1007645A1 Human serum inducible kinase (snk) |
06/14/2000 | EP1007638A1 Kcnq potassium channels and methods of modulating same |
06/14/2000 | EP1007637A1 Methods for increasing the efficiency of recombinant aav product |
06/14/2000 | EP1007630A1 Natural killer cell lines and methods of use |
06/14/2000 | EP1007628A1 Transgenic model for heart failure |
06/14/2000 | EP1007568A1 Collagen mimics |
06/14/2000 | EP1007567A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
06/14/2000 | EP1007566A2 Therapeutic use of the smr1 protein and active derivatives thereof |
06/14/2000 | EP1007565A2 Transgenic animals with disrupted npy y1 receptor genes |
06/14/2000 | EP1007564A1 Isolated dna encoding human calcium activated potassium channel |
06/14/2000 | EP1007563A1 Hm74a receptor |
06/14/2000 | EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e |
06/14/2000 | EP1007561A2 Novel conjugates of opioids and endogenous carriers |
06/14/2000 | EP1007560A1 Method for screening and transgenic model |
06/14/2000 | EP1007559A1 Genetically engineered cells which express bone morphogenetic proteins |
06/14/2000 | EP1007558A1 Familial mediterranean fever gene |
06/14/2000 | EP1007557A1 Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and |
06/14/2000 | EP1007556A2 Troponin subunits and fragments useful as angiogenesis inhibitors |
06/14/2000 | EP1007555A1 Tropoelastin derivatives |
06/14/2000 | EP1007554A1 Oil bodies and associated proteins as affinity matrices |
06/14/2000 | EP1007553A1 Zonula occludens toxin receptors |
06/14/2000 | EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
06/14/2000 | EP1007551A2 Vaccine against hpv |
06/14/2000 | EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION |
06/14/2000 | EP1007549A1 Compositions and methods for highly efficient transfection |
06/14/2000 | EP1007548A1 Tsetse thrombin inhibitor |
06/14/2000 | EP1007547A1 Peptides comprising a t-cell epitope specific to collagen ii |
06/14/2000 | EP1007546A1 Molecular mimetics of meningococcal b epitopes |
06/14/2000 | EP1007543A1 A method for stimulating red blood cell production |
06/14/2000 | EP1007541A1 Randomly generated glycopeptide combinatorial libraries |
06/14/2000 | EP1007540A1 Dna molecules encoding human nuclear receptor proteins |
06/14/2000 | EP1007539A1 Secreted proteins and polynucleotides encoding them |
06/14/2000 | EP1007537A1 Receptor protein designated 2f1 |
06/14/2000 | EP1007536A1 A novel human g-protein coupled receptor |
06/14/2000 | EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer |
06/14/2000 | EP1007534A1 Bh3 interacting domain death agonist |
06/14/2000 | EP1007107A2 Method for transporting a molecular substance in predetermined areas of eucaryotic cells |
06/14/2000 | EP1007099A1 Method of inducing apoptosis by reducing the level of thiamin |
06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
06/14/2000 | EP1007091A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
06/14/2000 | EP1007088A1 Recombinant porcine adenovirus vector |
06/14/2000 | EP1007083A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets |
06/14/2000 | EP1007082A1 Modified tumor necrosis factor |
06/14/2000 | EP1007081A1 Universal t-cell epitopes for anti-malarial vaccines |
06/14/2000 | EP1007079A1 Identification of broadly reactive dr restricted epitopes |
06/14/2000 | EP1007075A1 Structurally modified peptides resistant to peptidase degradation |
06/14/2000 | EP1007074A1 Hypothalamus-specific polypeptides |
06/14/2000 | EP1007073A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
06/14/2000 | EP1007072A1 Glial cell line-derived neurotrophic factor receptors |
06/14/2000 | EP1007069A1 Novel coding sequences |
06/14/2000 | EP1007065A1 Preparation of collagen |
06/14/2000 | EP1007048A1 Identification of agents for use in the treatment of alzheimer's disease |
06/14/2000 | EP1007000A2 Stable particle in liquid formulations |
06/14/2000 | EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer |
06/14/2000 | EP1006796A1 Compositions and methods for administering borrelia dna |
06/14/2000 | EP1006785A1 Antimicrobial proteins |
06/14/2000 | EP1006784A1 Glutathione-s-conjugate transport in plants |
06/14/2000 | EP1006783A1 Shoot meristem specific promoter sequences |
06/14/2000 | EP1006782A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
06/14/2000 | EP1006780A1 Two component plant cell lethality methods and compositions |
06/14/2000 | EP0979293A4 Transcriptional silencing elements and their binding factors |
06/14/2000 | EP0754193B1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
06/14/2000 | EP0667785B1 Method of treating non-streptococcal bacterial infections |
06/14/2000 | CN1256712A Plant pest control |
06/14/2000 | CN1256695A Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
06/14/2000 | CN1256628A Sustained-release compositions and method for preparing same |
06/14/2000 | CN1256626A Stable particle in liquid formulations |
06/14/2000 | CN1256315A New gene related to the development of human's nervous system and the protein encoded with it |
06/14/2000 | CN1256312A New human glutathione peroxidase and its code sequence, preparation and use |
06/14/2000 | CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line |
06/14/2000 | CN1256088A Soybean protein hydrolysates, their production and use |
06/14/2000 | CN1053451C Novel peptide compound with therapeutic active in blood coagulation reaction, its prep. and pharmaceutical composition thereof |
06/14/2000 | CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them |
06/13/2000 | US6075319 Plasma display panel device and method of fabricating the same |
06/13/2000 | US6075185 Synthetic DNA sequence having enhanced insecticidal activity in maize |
06/13/2000 | US6075137 Polynucleotide sequence coding polypeptide; for diagnosis and treatment of heart defects, hypotension, hypertension, angina pectoris, ulcers, psychotic and neurological disorders; for detecting agonist and antagonist of protein |
06/13/2000 | US6075128 Materials and methods for isolating IgA immunoglobulins |
06/13/2000 | US6075124 Mammalian polypeptide for the prevention and treatment of arthritis, lung inflammation, allergies, parasitic infections, inflammation, atherosclerosis and tumors; to promote wound healing and to regulate hematopoiesis |
06/13/2000 | US6075123 Cyclin-C variants, and diagnostic and therapeutic uses thereof |
06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |
06/13/2000 | US6075121 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
06/13/2000 | US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection |
06/13/2000 | US6075009 Neuropeptide Y analogues, compositions and methods of lowering blood pressure |